Previous Article | Next Article ![]()
Journal of Virology, November 1998, p. 8690-8696, Vol. 72, No. 11
Department of Viral Infection, Institute of
Medical Science, University of Tokyo, Shirokanedai 4-6-1, Minato-ku, Tokyo 108-86391 and
Department of Viral Disease and Vaccine
Control3 and
AIDS Research
Center,2 National Institute of Infectious
Disease,
Received 24 April 1998/Accepted 27 July 1998
Measles virus (MV) isolated in B95a cells, a marmoset B-cell line,
retains full pathogenicity for cynomolgus monkeys, while its derivative
obtained by adaptation to the growth in Vero cells, a monkey kidney
cell line, loses the pathogenic potential (F. Kobune, H. Sakata, and A. Sugiura, J. Virol. 64:700-705, 1990). Here, we show with a pair
of strains, a fresh isolate (9301B) in B95a cells and its Vero
cell-adapted form (9301V), that the in vivo attenuation parallels the
decrease of replication and syncytium-inducing capabilities in the
original B95a cells and that these in vitro phenotypes are attributable
to impediment of transcription, which is already obvious at the level
of primary transcription catalyzed by the virion-associated RNA
polymerase. On the other hand, cell fusion assays detected no
functional difference between the glycoproteins of the two viruses.
Essentially the same transcriptional impediment with reduced syncytium
induction following Vero cell adaptation was found with two other pairs of strains that had been similarly prepared. Nucleotide sequence comparison between the 9301B and 9301V viruses revealed that a few (at
most five) amino acid changes, which sporadically took place in the
polymerase (L and P proteins) and/or accessory V and C proteins, were
responsible for the in vitro and in vivo attenuation through adaptation
to growth in Vero cells.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Measles Virus Attenuation Associated with Transcriptional
Impediment and a Few Amino Acid Changes in the Polymerase and
Accessory Proteins
*
Corresponding author. Mailing address: Department of
Viral Infection, Institute of Medical Science, University of Tokyo,
Shirokanedai 4-6-1, Minato-ku, Tokyo 108-8639, Japan. Phone:
81-3-5449-5285. Fax: 81-3-5449-5409. E-mail:
ynagai{at}hgc.ims.u-tokyo.ac.jp
Journal of Virology, November 1998, p. 8690-8696, Vol. 72, No. 11
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|